Cross-talk between CD31 and the signaling lymphocytic activation molecule-associated protein during interferon-γ production against Mycobacterium tuberculosis

Maria Florencia Quiroga, Javier Oscar Jurado, Gustavo Javier Martínez, Virginia Pasquinelli, Rosa María Musella, Eduardo Abbate, Andrew C. Issekutz, María Marta Bracco, Alejandro Malbrán, Peter Allan Sieling, Eduardo Chuluyan, Verónica Edith García

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

10 Citas (Scopus)

Resumen

Effective host defense against tuberculosis requires Th1 cytokine responses. We studied the regulation of interferon (IFN)-γ production during tuberculosis by investigating the role of CD31, a receptor that attenuates T cell receptor signals. After antigen stimulation, CD3 +CD31+ blood lymphocytes decreased in healthy donors and in tuberculosis patients with robust Th1 responses to Mycobacterium tuberculosis and IFN-γ was secreted only by CD31- T cells. In contrast, in patients with weak Th1 cytokine responses to M. tuberculosis, the level of CD3+CD31+ lymphocytes was increased and IFN-γ production was low. Furthermore, the inverse relationship between CD31 expression and IFN-γ production was in contrast to signaling lymphocytic activation molecule (SLAM) expression, an IFN-γ inducer in tuberculosis. Interestingly, CD31 bound to SLAM-associated protein (SAP), an IFN-γ inhibitor in tuberculosis, and when CD31 and SAP were coexpressed in lymphocytes, their association inhibited the IFN-γ response to M. tuberculosis. Thus, CD31, when binding to SAP, interferes with Th1 responses, suggesting that CD31 has a key regulatory role in the signaling pathway(s) leading to the IFN-γ response to M. tuberculosis.

Idioma originalEnglish
Páginas (desde-hasta)1369-1378
Número de páginas10
PublicaciónJournal of Infectious Diseases
Volumen196
N.º9
DOI
EstadoPublished - nov. 1 2007

Nota bibliográfica

Funding Information:
Financial support: Agencia Nacional de Promoción Científica y Tecnológica (grant PICT 5-9638 to V.E.G and grant PICT 15069 E.C.); Antorchas Foundation (support to V.E.G.), University of Buenos Aires (grant UBACyT M030 to V.E.G and grant M09 to E.C.), Consejo Nacional de Investigaciones Científicas y Técnicas (grant PIP 5584 to V.E.G).

ASJC Scopus Subject Areas

  • Immunology and Allergy
  • Infectious Diseases

Huella

Profundice en los temas de investigación de 'Cross-talk between CD31 and the signaling lymphocytic activation molecule-associated protein during interferon-γ production against Mycobacterium tuberculosis'. En conjunto forman una huella única.

Citar esto